Costa, A.; Abruzzese, E.; Latagliata, R.; Mulas, O.; Carmosino, I.; Scalzulli, E.; Bisegna, M.L.; Ielo, C.; Martelli, M.; Caocci, G.;
et al. Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. J. Clin. Med. 2024, 13, 273.
https://doi.org/10.3390/jcm13010273
AMA Style
Costa A, Abruzzese E, Latagliata R, Mulas O, Carmosino I, Scalzulli E, Bisegna ML, Ielo C, Martelli M, Caocci G,
et al. Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of Clinical Medicine. 2024; 13(1):273.
https://doi.org/10.3390/jcm13010273
Chicago/Turabian Style
Costa, Alessandro, Elisabetta Abruzzese, Roberto Latagliata, Olga Mulas, Ida Carmosino, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Giovanni Caocci,
and et al. 2024. "Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia" Journal of Clinical Medicine 13, no. 1: 273.
https://doi.org/10.3390/jcm13010273
APA Style
Costa, A., Abruzzese, E., Latagliata, R., Mulas, O., Carmosino, I., Scalzulli, E., Bisegna, M. L., Ielo, C., Martelli, M., Caocci, G., & Breccia, M.
(2024). Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of Clinical Medicine, 13(1), 273.
https://doi.org/10.3390/jcm13010273
